The Bridging Antiplatelet Therapy With Cangrelor 2 Study

Abroad (travel likely)RecruitingPHASE4

Conditions

Coronary Arterial Disease (CAD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Florida Jacksonville, Jacksonville, Florida, United States
Contact: Study coordinator (Luis Ortega, MD, PhD) · Luis.Ortega@jax.ufl.edu · 904-244-2060
Contact: Study coordinator (Andrea Burton, MPH, CCRP) · andrea.burton@ufhealth.org · 904-244-5617
Contact: Principal Investigator (Luis Ortega, MD, PhD)

Study leads

Dominick J Angiolillo, MD, PhD
Study Chair
University of Florida College of Medicine - Jacksonville
Luis Ortegra-Paz, MD, PhD
Principal Investigator
University of Florida College of Medicine - Jacksonville

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Coronary Arterial Disease (CAD) · de Novo Lesions in Native Coronary Arteries

Abroad (travel likely)Recruiting

La Jolla, United States · Los Angeles, United States